Lars Slørdal
- Pharmacology top 1%
- Public Health, Environmental and Occupational Health top 5%
- Toxicology top 0.2%
- Rheumatology top 2%
- Molecular Biology
- Co-authors
- A. KlovningJan Magnus BjordalAnne Elisabeth LjunggrenAnders AndersenJørg MørlandOlav SpigsetDavid J. WarrenJarle Aarbakke
- Topics
- Acute Lymphoblastic Leukemia research (19 papers)Forensic Toxicology and Drug Analysis (17 papers)Pharmaceutical studies and practices (17 papers)
- Cited by
- ToxicologyPharmacologyRheumatology
- Journals
- Proceedings of the National Academy of SciencesThe Journal of ImmunologyAnalytical Biochemistry
- Partner nations
- NorwayUnited StatesSingapore
In The Last Decade
Lars Slørdal
129 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 145
- Pharmacology 650
- Public Health, Environmental and Occupational Health 496
- Toxicology 393
- Rheumatology 377
- Molecular Biology 291
Countries citing papers authored by Lars Slørdal
This map shows the geographic impact of Lars Slørdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Slørdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Slørdal more than expected).
Fields of papers citing papers by Lars Slørdal
This network shows the impact of papers produced by Lars Slørdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Slørdal. The network helps show where Lars Slørdal may publish in the future.
Co-authorship network of co-authors of Lars Slørdal
This figure shows the co-authorship network connecting the top 25 collaborators of Lars Slørdal. A scholar is included among the top collaborators of Lars Slørdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Slørdal. Lars Slørdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 41 | |
| 3 | 106 | |
| 4 | 3 | |
| 5 | 32 | |
| 6 | Benzodiazepinliknende hypnotika – holdninger og forskrivningspraksis blant allmennleger | 1 |
| 7 | Glukosamin – den store sukkerpillebløffen | 1 |
| 8 | [Clinical use of COX inhibitors--a consensus]. | 5 |
| 9 | [Generic drugs instead of brand drugs prescriptions--long overdue]. | 9 |
| 10 | Klinisk bruk av COX-hemmere – en konsensus | 2 |
| 11 | Forskrivning av virkestoff i stedet for preparat – på høy tid | 1 |
| 12 | Grunnleggende farmakokinetikk – distribusjon | 2 |
| 13 | Grunnleggende farmakokinetikk – absorpsjon | 1 |
| 14 | [What information is given on adverse drug reactions from new drugs?]. | 1 |
| 15 | Hvilken informasjon gis om bivirkninger av nye legemidler | 1 |
| 16 | Selektive COX-2-hemmere – holdninger og forskrivningspraksis blant allmennpraktikere | 1 |
| 17 | 13 | |
| 18 | 11 | |
| 19 | 29 | |
| 20 | 7 |
About Lars Slørdal
Lars Slørdal is a scholar working on Toxicology, Family Practice and Geriatrics and Gerontology, having authored 138 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (19 papers), Forensic Toxicology and Drug Analysis (17 papers) and Pharmaceutical studies and practices (17 papers). The work is most often cited by research in Toxicology (393 citations), Pharmacology (650 citations) and Rheumatology (377 citations). Lars Slørdal has collaborated with scholars based in Norway, United States and Singapore. Frequent co-authors include A. Klovning, Jan Magnus Bjordal, Anne Elisabeth Ljunggren, Anders Andersen, Jørg Mørland, Olav Spigset, David J. Warren, Jarle Aarbakke, Jørgen G. Bramness and David J. Warren. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.